Radiomedix Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RADIOMEDIX, and what generic alternatives to RADIOMEDIX drugs are available?
RADIOMEDIX has one approved drug.
There are three US patents protecting RADIOMEDIX drugs.
There are seven patent family members on RADIOMEDIX drugs in six countries.
Summary for Radiomedix
| International Patents: | 7 |
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Radiomedix
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Radiomedix | DETECTNET | copper cu-64 dotatate | SOLUTION;INTRAVENOUS | 213227-001 | Sep 3, 2020 | RX | Yes | Yes | 10,383,961 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Radiomedix | DETECTNET | copper cu-64 dotatate | SOLUTION;INTRAVENOUS | 213227-001 | Sep 3, 2020 | RX | Yes | Yes | 11,160,888 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Radiomedix | DETECTNET | copper cu-64 dotatate | SOLUTION;INTRAVENOUS | 213227-001 | Sep 3, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Radiomedix Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Poland | 2750717 | ⤷ Try a Trial |
| Hungary | E052723 | ⤷ Try a Trial |
| Denmark | 3536346 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
